{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:15:38Z","timestamp":1782954938597,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.numecd.2024.02.006","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T16:30:30Z","timestamp":1708187430000},"page":"1798-1806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Long-term clinical outcomes and management of hypertriglyceridemia in children with Apo-CII deficiency"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0015-9807","authenticated-orcid":false,"given":"Merve","family":"Yoldas Celik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Canda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2564-7420","authenticated-orcid":false,"given":"Havva","family":"Yazici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fehime","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse","family":"Yuksel Yanbolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Atik Altinok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7877-6103","authenticated-orcid":false,"given":"Erhan","family":"Pariltay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haluk","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sema","family":"Kalkan Ucar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"Coker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.numecd.2024.02.006_bib1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MOL.0b013e3283471972","article-title":"Genetic bases of hypertriglyceridemic phenotypes","volume":"22","author":"Johansen","year":"2011","journal-title":"Curr Opin Lipidol"},{"issue":"11","key":"10.1016\/j.numecd.2024.02.006_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11883-020-00885-1","article-title":"Familial chylomicronemia syndrome (FCS): recent data on diagnosis and treatment","volume":"22","author":"Gallo","year":"2020","journal-title":"Curr Atherosclerosis Rep"},{"key":"10.1016\/j.numecd.2024.02.006_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2017.10.025","article-title":"Apolipoprotein C-II: new findings related to genetics, biochemistry, and role in triglyceride metabolism","volume":"267","author":"Wolska","year":"2017","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.numecd.2024.02.006_bib4","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1210\/jc.2011-3213","article-title":"Evaluation and treatment of hypertriglyceridemia: an endocrine society clinical practice guideline","volume":"97","author":"Berglund","year":"2012","journal-title":"J Clin Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.numecd.2024.02.006_bib5","first-page":"50","article-title":"Hypertriglyceridemia in a 3-month infant-possibly LPL deficiency","volume":"2","author":"Manocha","year":"2008","journal-title":"Advances in Medical and Dental Sciences"},{"issue":"1","key":"10.1016\/j.numecd.2024.02.006_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ecl.2008.11.005","article-title":"Hypertriglyceridemia: impact and treatment","volume":"38","author":"Goldberg","year":"2009","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"1","key":"10.1016\/j.numecd.2024.02.006_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2362.1981.tb01768.x","article-title":"Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion","volume":"11","author":"Miller","year":"1981","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"10.1016\/j.numecd.2024.02.006_bib8","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1210\/jc.2016-3903","article-title":"A novel APOC2 missense mutation causing apolipoprotein C-II deficiency with severe triglyceridemia and pancreatitis","volume":"102","author":"Ueda","year":"2017","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.numecd.2024.02.006_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/TACG.S243148","article-title":"A novel APOC2 mutation in a Colombian patient with recurrent hypertriglyceridemic pancreatitis","volume":"13","author":"Pinilla-Monsalve","year":"2020","journal-title":"Appl Clin Genet"},{"issue":"23","key":"10.1016\/j.numecd.2024.02.006_bib10","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM197806082982301","article-title":"Hypertriglyceridemia associated with deficiency of apolipoprotein C-II","volume":"298","author":"Breckenridge","year":"1978","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.numecd.2024.02.006_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.10702","article-title":"Diagnosis and management of type I and type V hyperlipoproteinemia","volume":"19","author":"Gotoda","year":"2012","journal-title":"J Atherosclerosis Thromb"},{"issue":"11","key":"10.1016\/j.numecd.2024.02.006_bib12","first-page":"1289","article-title":"Severe hyperchylomicronemia in two infants with novel APOC2 gene mutation","volume":"31","author":"Kose","year":"2018","journal-title":"J Pediatr Endocrinol Metabol"},{"issue":"4","key":"10.1016\/j.numecd.2024.02.006_bib13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.pan.2020.03.008","article-title":"Successful management of acute pancreatitis due to apolipoprotein C-II deficiency in a 37-day-old infant","volume":"20","author":"Y\u0131ld\u0131z","year":"2020","journal-title":"Pancreatology"},{"issue":"2","key":"10.1016\/j.numecd.2024.02.006_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2362.1992.tb01941.x","article-title":"Apolipoprotein C-II deficiency syndrome due to apo C-IIHamburg: clinical and biochemical features and HphI restriction enzyme polymorphism","volume":"22","author":"Beil","year":"1992","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"10.1016\/j.numecd.2024.02.006_bib15","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI113756","article-title":"Donor splice site mutation in the apolipoprotein (Apo) C-II gene (Apo C-IIHamburg) of a patient with Apo C-II deficiency","volume":"82","author":"Fojo","year":"1988","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.numecd.2024.02.006_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12944-022-01631-z","article-title":"Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia","volume":"21","author":"Paragh","year":"2022","journal-title":"Lipids Health Dis"},{"issue":"4","key":"10.1016\/j.numecd.2024.02.006_bib17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/17512433.2022.2094768","article-title":"Safety and efficacy of therapies for chylomicronemia","volume":"15","author":"Shamsudeen","year":"2022","journal-title":"Expet Rev Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.numecd.2024.02.006_bib18","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jacl.2015.12.023","article-title":"Editorial commentary: dietary management of familial chylomicronemia syndrome","volume":"10","author":"Williams","year":"2016","journal-title":"Journal of Clinical Lipidology"},{"issue":"5","key":"10.1016\/j.numecd.2024.02.006_bib19","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3390\/nu15051088","article-title":"Nutritional treatment of hypertriglyceridemia in childhood: from healthy-heart counselling to life-saving diet","volume":"15","author":"Capra","year":"2023","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.numecd.2024.02.006_bib20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/21678707.2017.1311784","article-title":"Investigated treatments for lipoprotein lipase deficiency and related metabolic disorders","volume":"5","author":"Lee","year":"2017","journal-title":"Expert Opinion on Orphan Drugs"},{"issue":"3","key":"10.1016\/j.numecd.2024.02.006_bib21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ymgme.2007.10.007","article-title":"Monogenic pediatric dyslipidemias: classification, genetics and clinical spectrum","volume":"93","author":"Rahalkar","year":"2008","journal-title":"Mol Genet Metabol"},{"issue":"8","key":"10.1016\/j.numecd.2024.02.006_bib22","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1073\/pnas.86.8.2663","article-title":"Medium-chain fatty acid binding to albumin and transfer to phospholipid bilayers","volume":"86","author":"Hamilton","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"10.1016\/j.numecd.2024.02.006_bib23","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1080\/10408398.2021.1873729","article-title":"Medium chain triglyceride and medium-and long chain triglyceride: metabolism, production, health impacts and its applications\u2013a review","volume":"62","author":"Lee","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"6","key":"10.1016\/j.numecd.2024.02.006_bib24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/17512433.2018.1480368","article-title":"Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome","volume":"11","author":"Chaudhry","year":"2018","journal-title":"Expet Rev Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.numecd.2024.02.006_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/MOL.0000000000000665","article-title":"Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence","volume":"31","author":"Sherratt","year":"2020","journal-title":"Curr Opin Lipidol"},{"issue":"9","key":"10.1016\/j.numecd.2024.02.006_bib26","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1073\/pnas.94.9.4318","article-title":"Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors \u03b1 and \u03b3","volume":"94","author":"Kliewer","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.numecd.2024.02.006_bib27","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11883-011-0210-3","article-title":"Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis","volume":"13","author":"Wei","year":"2011","journal-title":"Curr Atherosclerosis Rep"},{"issue":"10","key":"10.1016\/j.numecd.2024.02.006_bib28","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1080\/14656566.2019.1609942","article-title":"Clinical trials of eicosapentaenoic acid (EPA) prescription products for the treatment of hypertriglyceridemia","volume":"20","author":"Doggrell","year":"2019","journal-title":"Expet Opin Pharmacother"},{"issue":"9","key":"10.1016\/j.numecd.2024.02.006_bib29","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1542\/pir.2016-0138","article-title":"Approach to hypertriglyceridemia in the pediatric population","volume":"38","author":"Valaiyapathi","year":"2017","journal-title":"Pediatr Rev"},{"issue":"1","key":"10.1016\/j.numecd.2024.02.006_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12937-022-00826-5","article-title":"Effect of omega-3 supplementation on lipid profile in children and adolescents: a systematic review and meta-analysis of randomized clinical trials","volume":"22","author":"Khorshidi","year":"2023","journal-title":"Nutr J"},{"issue":"8","key":"10.1016\/j.numecd.2024.02.006_bib31","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1515\/jpem-2018-0409","article-title":"Effect of supplementation with omega-3 fatty acids on hypertriglyceridemia in pediatric patients with obesity","volume":"32","author":"Del-R\u00edo-Navarro","year":"2019","journal-title":"J Pediatr Endocrinol Metabol"},{"issue":"19","key":"10.1016\/j.numecd.2024.02.006_bib32","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/01.CIR.98.19.2088","article-title":"Mechanism of action of fibrates on lipid and lipoprotein metabolism","volume":"98","author":"Staels","year":"1998","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.numecd.2024.02.006_bib33","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MOL.0b013e3283319a1d","article-title":"Severe hypertriglyceridemia and pancreatitis: presentation and management","volume":"20","author":"Ewald","year":"2009","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"10.1016\/j.numecd.2024.02.006_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11883-022-01000-2","article-title":"Childhood hypertriglyceridemia: is it time for a new approach?","volume":"24","author":"Sunil","year":"2022","journal-title":"Curr Atherosclerosis Rep"},{"issue":"5","key":"10.1016\/j.numecd.2024.02.006_bib35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11883-022-01013-x","article-title":"The role of non-statin lipid-lowering medications in youth with hypercholesterolemia","volume":"24","author":"Butt","year":"2022","journal-title":"Curr Atherosclerosis Rep"},{"issue":"1","key":"10.1016\/j.numecd.2024.02.006_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13023-017-0663-8","article-title":"Safety and potential efficacy of gemfibrozil as a supportive treatment for children with late infantile neuronal ceroid lipofuscinosis and other lipid storage disorders","volume":"12","author":"Kim","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"10.1016\/j.numecd.2024.02.006_bib37","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jclinpath-2021-207719","article-title":"Hypertriglyceridaemia: an update","volume":"75","author":"Wierzbicki","year":"2022","journal-title":"J Clin Pathol"},{"issue":"1\u20133","key":"10.1016\/j.numecd.2024.02.006_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-4274(02)00010-3","article-title":"Myopathy and rhabdomyolysis with lipid-lowering drugs","volume":"128","author":"Hodel","year":"2002","journal-title":"Toxicol Lett"},{"issue":"3","key":"10.1016\/j.numecd.2024.02.006_bib39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00210-002-0660-9","article-title":"Cell-specific toxicity of fibrates in human embryonal rhabdomyosarcoma cells","volume":"367","author":"Maiguma","year":"2003","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"21","key":"10.1016\/j.numecd.2024.02.006_bib40","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020390","article-title":"Fenofibrate monotherapy-induced rhabdomyolysis in a patient with post-pancreatitis diabetes mellitus: a rare case report and a review of the literature","volume":"99","author":"Zhou","year":"2020","journal-title":"Medicine (Baltim)"},{"issue":"12","key":"10.1016\/j.numecd.2024.02.006_bib41","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00228-009-0723-7","article-title":"Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report","volume":"65","author":"Wu","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.numecd.2024.02.006_bib42","first-page":"RV17054","article-title":"Current diagnosis and management of primary chylomicronemia","author":"Okazaki","year":"2021","journal-title":"J Atherosclerosis Thromb"},{"issue":"12","key":"10.1016\/j.numecd.2024.02.006_bib43","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJM199609193351203","article-title":"Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene","volume":"335","author":"Benlian","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2024.02.006_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4721357","article-title":"Management of hypertriglyceridemia induced acute pancreatitis","volume":"2018","author":"Garg","year":"2018","journal-title":"BioMed Res Int"},{"issue":"4","key":"10.1016\/j.numecd.2024.02.006_bib45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.pan.2015.02.010","article-title":"The role of apheresis in hypertriglyceridemia-induced acute pancreatitis: a systematic review","volume":"15","author":"Click","year":"2015","journal-title":"Pancreatology"},{"issue":"2","key":"10.1016\/j.numecd.2024.02.006_bib46","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1172\/JCI112332","article-title":"Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients","volume":"77","author":"Baggio","year":"1986","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.numecd.2024.02.006_bib47","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/jth.15185","article-title":"Prophylactic fresh frozen plasma and platelet transfusion have a prothrombotic effect in patients with liver disease","volume":"19","author":"von Meijenfeldt","year":"2021","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.numecd.2024.02.006_bib48","first-page":"2020","article-title":"Experimental therapeutics for challenging clinical care of a patient with an extremely rare homozygous APOC2 mutation","author":"Ueda","year":"2020","journal-title":"Case Reports in Endocrinology"},{"issue":"2","key":"10.1016\/j.numecd.2024.02.006_bib49","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1124\/jpet.115.229740","article-title":"Creation of apolipoprotein C-II (ApoC-II) mutant mice and correction of their hypertriglyceridemia with an ApoC-II mimetic peptide","volume":"356","author":"Sakurai","year":"2016","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"528","key":"10.1016\/j.numecd.2024.02.006_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw7905","article-title":"A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides","volume":"12","author":"Wolska","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.numecd.2024.02.006_bib51","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.omtm.2020.07.011","article-title":"AAV-mediated ApoC2 gene therapy: reversal of severe hypertriglyceridemia and rescue of neonatal death in ApoC2-deficient hamsters","volume":"18","author":"Yang","year":"2020","journal-title":"Molecular Therapy - Methods & Clinical Development"},{"issue":"null","key":"10.1016\/j.numecd.2024.02.006_bib52","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.2147\/DDDT.S224771","article-title":"Volanesorsen in the treatment of familial chylomicronemia syndrome or hypertriglyceridaemia: design, development and place in therapy","volume":"14","author":"Esan","year":"2020","journal-title":"Drug Des Dev Ther"},{"issue":"528","key":"10.1016\/j.numecd.2024.02.006_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw7905","article-title":"A dual apolipoprotein C-II mimetic\u2013apolipoprotein C-III antagonist peptide lowers plasma triglycerides","volume":"12","author":"Wolska","year":"2020","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.numecd.2024.02.006_bib54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12944-015-0006-5","article-title":"Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome","volume":"14","author":"Meyers","year":"2015","journal-title":"Lipids Health Dis"},{"issue":"4","key":"10.1016\/j.numecd.2024.02.006_bib55","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1507\/endocrj.K03-115","article-title":"Metabolic disorders in adult growth hormone deficiency: a study of 110 patients at a single institute in Japan","volume":"53","author":"Itoh","year":"2006","journal-title":"Endocr J"},{"issue":"5","key":"10.1016\/j.numecd.2024.02.006_bib56","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1043-2760(98)00050-2","article-title":"Dyslipidaemia in adult growth hormone (GH) deficiency and the effect of GH replacement therapy: a review","volume":"9","author":"Christ","year":"1998","journal-title":"Trends Endocrinol Metabol"},{"issue":"3","key":"10.1016\/j.numecd.2024.02.006_bib57","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00041433-199405030-00002","article-title":"Growth hormone and hepatic lipoprotein metabolism","volume":"5","author":"Angelin","year":"1994","journal-title":"Curr Opin Lipidol"},{"issue":"15","key":"10.1016\/j.numecd.2024.02.006_bib58","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1073\/pnas.89.15.6983","article-title":"Importance of growth hormone for the induction of hepatic low density lipoprotein receptors","volume":"89","author":"Rudling","year":"1992","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475324000772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475324000772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T15:26:29Z","timestamp":1717860389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475324000772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0939475324000772"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2024.02.006","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term clinical outcomes and management of hypertriglyceridemia in children with Apo-CII deficiency","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2024.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}